Home About us Current issue Back issues Submission Instructions Advertise Contact Login   

Search Article 
  
Advanced search 
 
Saudi Journal of Kidney Diseases and Transplantation
Users online: 1679 Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size 

    Article Cited by others

ORIGINAL ARTICLE

Rapid improvement in renal function in patients with multiple myeloma and renal failure treated with bortezomib

Qayum Abdul, Aleem Aamer, Al Diab Abdel Rehman, Niaz Faraz, Al Momen Abdel Karim

Year : 2010| Volume: 21| Issue : 1 | Page no: 63-68

   This article has been cited by
 
1 Immunomodulatory drugs and proteasome inhibitors in the treatment of multiple myeloma patients with renal failure [Leki immunomoduluja̧ce oraz inhibitory proteasomów w leczeniu chorych na szpiczaka plazmocytowego z niewydolnościa̧ nerek]
Charliński, G. and Ostrowski, G. and Wiater, E.
Acta Haematologica Polonica. 2012; 43(2 PARTB): 173-186
[Pubmed]  [Google Scholar]
2 Novel therapeutic agents for the management of patients with multiple myeloma and renal impairment
Chanan-Khan, A.A. and San Miguel, J.F. and Jagannath, S. and Ludwig, H. and Dimopoulos, M.A.
Clinical Cancer Research. 2012; 18(8): 2145-2163
[Pubmed]  [Google Scholar]
3 Effectiveness of first line treatment with bortezomib prior to autologous stem cell transplantation for multiple myeloma [Ocena učinkovitosti prvega zdravljenja z bortezomibom pred avtologno presaditvijo krvotvornih matičnih celic pri diseminiranem plazmocitomu]
Černelč, P. and Kodre, V.
Zdravniski Vestnik. 2012; 81(4): 304-311
[Pubmed]  [Google Scholar]
4 Management of myeloma-associated renal dysfunction in the era of novel therapies
Gaballa, M.R. and Laubach, J.P. and Schlossman, R.L. and Redman, K. and Noonan, K. and Mitsiades, C.S. and Ghobrial, I.M. and Munshi, N. and Anderson, K.C. and Richardson, P.G.
Expert Review of Hematology. 2012; 5(1): 51-68
[Pubmed]  [Google Scholar]
5 A systematic review on the use of bortezomib in multiple myeloma patients with renal impairment: What is the published evidence?
Piro, E. and Molica, S.
Acta Haematologica. 2011; 126(3): 163-168
[Pubmed]  [Google Scholar]
6 Partial recovery of kidney function for an autologous transplant in a patient with chronic kidney disease and multiple myeloma [Recuperación parcial de la función renal tras trasplante autólogo en paciente con enfermedad renal crónica y mieloma múltiple]
de Alarcón Jiménez, R.M. and Meroño, S.R. and Fernández, G.M.Á. and Hernández, M.A.G. and Parreño, M.J.N. and Griñó, C.J. and Pedrinaci, E.Z. and Núñez, M.M.
Nefrologia. 2011; 31(2): 238-240
[Pubmed]  [Google Scholar]
7 Safety evaluation of bortezomib in multiple myeloma patients with severe renal failure
Muta, T. and Nakanishi, H. and Yasunaga, M. and Senba, S. and Murakami, H. and Kan, S. and Ueda, Y. and Fujisaki, T.
Japanese Journal of Cancer and Chemotherapy. 2011; 38(2): 237-241
[Pubmed]  [Google Scholar]

 

Read this article